close menu

Our Portfolio


2.2gForce has been established to commercialise energy dampers developed by University of Canterbury researchers.


AuramerBio is a point-of-care diagnostics development company. Its novel technology allows us to accurately measure extremely low levels of biologically relevant molecules at the point-of-care.

Avalia Immunotherapies

Platform technology that can be used to design new treatments for cancer, infectious disease and allergy, with an initial focus centring on cancer immunotherapy. Technology from the Malaghan Institute for Medical Research and Victoria University of Wellington.


Lab-on-a-chip biosensor technology for interference-free wastewater monitoring to increase the resource and energy efficiency of large-scale industrial processes. Technology developed by Lincoln Agritech Ltd.

Cirrus Materials Science Ltd

Novel electroplating nanotechnology chemistry to significantly improve surface coating performance, targeting the aerospace and consumer electronics industries.


EdPotential delivers software-as-a-service products based on advanced algorithms and data analysis capability, enabling schools to make more informed decisions, enhance teaching practice, saving teachers time and improving student outcomes.


Ferronova is an Adelaide-headquartered medical device company, bringing together patented magnetic probe technology from University of South Australia and magnetic nanoparticle technology from Victoria University of Wellington.

Fluent IQ

FluentIQ has developed some disruptive technology that enables an assessment of someone’s English language communication abilities, in a real-world context.

Hapai Transfer Systems

HT Systems is a start-up company developing a range of innovative low force lift and transfer devices to radically improve the independence and mobility of frail patients.


Hi-Aspect is developing a range of new ingredients for the cosmetics and healthcare industries, based on its protein fibril technology.

Hot Lime Labs

Hot Lime Labs is developing CO2 capture technology for the commercial greenhouses to increase crop yields and transition to low carbon renewable energy sources.

Inhibit Coatings

Inhibit Coating’s surface coatings display strong antimicrobial activity against E. coli, and also prevent the settlement of diatoms (microscopic algae). Preliminary antifouling tests show very good static resistance to biofouling in the New Zealand marine environment.

Invert Robotics

Invert Robotics provides non-destructive inspection services using mobile climbing robots. The proprietary robotic platform can be used for the inspection of mission and business critical assets in the dairy, food and beverage, aviation, petrochemical, and industrial chemical markets.

Koti Technologies

Koti Technologies is commercialising thin film ceramic coatings. Koti’s breakthrough high performance photocatalysts are applicable to a number of market applications, from air and water purification to antimicrobial coatings and water splitting for hydrogen generation.

Mars Bioimaging

Colour x-ray CT imaging. This technology was developed at the University of Canterbury and CERN.


Building Information Modelling is a new way of approaching the design and documentation of building projects. Computer aided design (CAD) models that hold product information.

Objective Acuity

Objective Acuity is a digital health company that is developing a patented system to objectively, accurately and quickly test visual acuity and other health issues, licensed from The University of Auckland, New Zealand.

Orbis Diagnostics

Orbis Diagnostics is developing in-line milking measurement for protein, fat, somatic cell and progesterone.

Photonic Innovations

Reliable, calibration-free gas detection using laser spectroscopy. This technology was developed at the University of Otago.


Silventum is a company that will commercialise novel nanochemistry technology developed at the University of Otago which confers dental filling materials with resistance to bacterial infection.

Tiro Medical

Tiro Medical is a company in the medical device sector, currently focusing to commercialize two main technologies, one is a breast cancer screening system and the other is a decision support tool for use in Intensive Care Units (ICU's). The basis of both these technologies originates from research at the University of Canterbury’s biomedical engineering department.


Real-time bacteria detection technology applied to the food industry for food safety and quality. Developed at the University of Canterbury.